Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts.

Abstract:

:Bcl-2 is a key inhibitor of a broad range of apoptotic pathways, yet neither the mechanism of action nor the role of Bcl-2 subcellular localization are well understood. The subcellular localization of Bcl-2 includes the mitochondrial membrane as well as the contiguous membrane of the endoplasmic reticulum and nuclear envelope. Most studies suggest that the ability of Bcl-2 to confer cell survival is dependent upon its localization to the mitochondria. In this manuscript, we show that Bcl-2 targeted to the endoplasmic reticulum can inhibit Myc-, but not etoposide-induced apoptosis in the Rat-1 fibroblast cell line. By contrast, wild type Bcl-2 can inhibit apoptosis triggered by either death agonist. We further show both Myc and etoposide trigger disruption of mitochondrial membrane potential (MMP) and induce poly-ADP ribose polymerase (PARP) cleavage, but release of calcium was not evident. Bcl-2 abrogates apoptosis at or upstream of MMP depletion showing that Bcl-2 does not have to reside at the mitochondria to prevent apoptosis. These results further elucidate the biochemical events associated with Myc- and etoposide-induced apoptosis and significantly advance our understanding of Bcl-2 function.

journal_name

Oncogene

journal_title

Oncogene

authors

Lee ST,Hoeflich KP,Wasfy GW,Woodgett JR,Leber B,Andrews DW,Hedley DW,Penn LZ

doi

10.1038/sj.onc.1202716

subject

Has Abstract

pub_date

1999-06-10 00:00:00

pages

3520-8

issue

23

eissn

0950-9232

issn

1476-5594

journal_volume

18

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.

    abstract::Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional acti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.508

    authors: Robinson JL,Hickey TE,Warren AY,Vowler SL,Carroll T,Lamb AD,Papoutsoglou N,Neal DE,Tilley WD,Carroll JS

    更新日期:2014-12-11 00:00:00

  • CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

    abstract::The serine threonine checkpoint kinase 2 (CHK2) is a critical protein involved in the DNA damage-response pathway, which is activated by phosphorylation inducing cellular response such as DNA repair, cell-cycle regulation or apoptosis. Although CHK2 activation mechanisms have been amply described, very little is known...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.495

    authors: García-Limones C,Lara-Chica M,Jiménez-Jiménez C,Pérez M,Moreno P,Muñoz E,Calzado MA

    更新日期:2016-08-18 00:00:00

  • Therapeutic approaches to AIDS-related malignancies.

    abstract::The introduction of highly active antiretroviral therapy (HAART) has changed dramatically the landscape of HIV disease. Deaths from AIDS-related diseases have been reduced by 75% since protease inhibitor therapy and combination antiretroviral therapy came into use in late 1995. While KS is declining, the situation for...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206771

    authors: Berretta M,Cinelli R,Martellotta F,Spina M,Vaccher E,Tirelli U

    更新日期:2003-09-29 00:00:00

  • Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.

    abstract::p53 is known to play a role in iron homeostasis and is required for FDXR-mediated iron metabolism via iron regulatory protein 2 (IRP2). Interestingly, p53 is frequently mutated in tumors wherein iron is often accumulated, suggesting that mutant p53 may exert its gain of function by altering iron metabolism. In this st...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0876-5

    authors: Zhang Y,Feng X,Zhang J,Chen M,Huang E,Chen X

    更新日期:2019-08-01 00:00:00

  • A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).

    abstract::A distinctive subset of renal carcinomas is associated with Xp11. 2 translocations and resulting TFE3 gene fusions (PRCC-TFE3, PSF-TFE3, NONO-TFE3, ASPL-TFE3), encoding related aberrant transcription factors. We report the cloning of a novel clathrin heavy-chain gene (CLTC)-TFE3 gene fusion resulting from a t(X;17)(p1...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206686

    authors: Argani P,Lui MY,Couturier J,Bouvier R,Fournet JC,Ladanyi M

    更新日期:2003-08-14 00:00:00

  • RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression.

    abstract::RNA-binding proteins play key roles in the posttranscriptional regulation of mRNA during cancer progression. Here, we show that RNA-binding motif protein 43 (RBM43) is significantly downregulated in human tumors, and its low expression is correlated with poor prognosis in patients with HCC. Overexpression of RBM43 sup...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1380-7

    authors: Feng H,Liu J,Qiu Y,Liu Y,Saiyin H,Liang X,Zheng F,Wang Y,Jiang D,Wang Y,Yu L,Su W,Shen S,Wu J

    更新日期:2020-08-01 00:00:00

  • The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements.

    abstract::The hepatitis B virus (HBV) X protein (pX) stimulates transcription regulated by cis-acting elements that control many viral and cellular genes, including the c-myc and the c-fos proto-oncogenes. Using several c-fos promoter deletion mutants, we found the serum-responsive element (SRE) located at -315, the modified TP...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Avantaggiati ML,Natoli G,Balsano C,Chirillo P,Artini M,De Marzio E,Collepardo D,Levrero M

    更新日期:1993-06-01 00:00:00

  • Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo.

    abstract::Mesenchymal stem cells (MSCs) are a kind of adult stem cells that can be isolated easily from bone marrow, adipose tissue, umbilical cord and many other tissues. MSCs have been shown to specifically migrate to inflammatory sites, including tumors, and hold great promise as tumor-specific vectors to deliver antitumor a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.458

    authors: Xu C,Lin L,Cao G,Chen Q,Shou P,Huang Y,Han Y,Wang Y,Shi Y

    更新日期:2014-10-16 00:00:00

  • The transforming oncoproteins determine the mechanism by which p53 suppresses cell transformation: pRb-mediated growth arrest or apoptosis.

    abstract::To investigate the mechanisms by which p53 suppresses cell transformation, we used the simian virus 40 (SV40) large T antigen (LTag), the adenovirus E1a proteins, and an activated ras protein (EJ-ras), to examine different pathways of transformation for their susceptibility to suppression by p53: While p53 can suppres...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hansen R,Reddel R,Braithwaite A

    更新日期:1995-12-21 00:00:00

  • Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.

    abstract::The human INK4a gene locus encodes two structurally unrelated tumor suppressor proteins, p16(INK4a) and p14(ARF), which are frequently inactivated in human cancer. Whereas p16(INK4a) acts through engagement of the Rb-cdk4/6-cyclin D pathway, both the pro-apoptotic and cell cycle-regulatory functions of p14(ARF) were s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205458

    authors: Hemmati PG,Gillissen B,von Haefen C,Wendt J,Stärck L,Güner D,Dörken B,Daniel PT

    更新日期:2002-05-09 00:00:00

  • Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice.

    abstract::The von Hippel-Lindau tumor suppressor pVHL regulates the stability of hypoxia-inducible factors (HIF)-1 and -2, oxygen-sensitive basic helix-loop-helix transcription factors, which mediate the hypoxic induction of angiogenic growth factors such as vascular endothelial growth factor. Loss of pVHL function results in c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.160

    authors: Rankin EB,Rha J,Unger TL,Wu CH,Shutt HP,Johnson RS,Simon MC,Keith B,Haase VH

    更新日期:2008-09-11 00:00:00

  • Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.

    abstract::One prominent effect of IFNs is their cell growth-inhibitory activity. The mechanism behind this inhibition of proliferation is still not fully understood. In this study, the effect of IFN-alpha treatment on cell cycle progression has been analysed in three lymphoid cell lines, Daudi, U-266 and H9. Examination of the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202609

    authors: Sangfelt O,Erickson S,Castro J,Heiden T,Gustafsson A,Einhorn S,Grandér D

    更新日期:1999-05-06 00:00:00

  • Mutation of GATA3 in human breast tumors.

    abstract::GATA3 is an essential transcription factor that was first identified as a regulator of immune cell function. In recent microarray analyses of human breast tumors, both normal breast luminal epithelium and estrogen receptor (ESR1)-positive tumors showed high expression of GATA3. We sequenced genomic DNA from 111 breast...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207966

    authors: Usary J,Llaca V,Karaca G,Presswala S,Karaca M,He X,Langerød A,Kåresen R,Oh DS,Dressler LG,Lønning PE,Strausberg RL,Chanock S,Børresen-Dale AL,Perou CM

    更新日期:2004-10-07 00:00:00

  • tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors.

    abstract::A search for protein tyrosine kinases expressed during murine cardiogenesis resulted in the isolation of a novel tyrosine kinase, designated tek, which maps to mouse chromosome 4 between the brown and pmv-23 loci. The deduced amino acid sequence of tek predicts that it encodes a putative receptor tyrosine kinase that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Dumont DJ,Yamaguchi TP,Conlon RA,Rossant J,Breitman ML

    更新日期:1992-08-01 00:00:00

  • Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity.

    abstract::Immunopurified mouse p53 proteins were used to gain experimental access to the mechanisms underlying nonprimate p53 directed suppression of SV40 origin directed DNA replication in vivo. In replication competent HeLa cell extracts containing exogenous T antigen, mouse p53 blocks T antigen dependent DNA synthesis as in ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Stürzbecher HW,Brain R,Maimets T,Addison C,Rudge K,Jenkins JR

    更新日期:1988-10-01 00:00:00

  • Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

    abstract::We screened cdc2 kinase inhibitors from cultured mediums of micro organisms using purified mouse cyclin B-cdc2 kinase and a specific substrate peptide for cdc2 kinase. A selective inhibitor of cdc2 kinase was isolated from the cultured medium of Aspergillus species F-25799, and identified as butyrolactone I. Butyrolac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kitagawa M,Okabe T,Ogino H,Matsumoto H,Suzuki-Takahashi I,Kokubo T,Higashi H,Saitoh S,Taya Y,Yasuda H

    更新日期:1993-09-01 00:00:00

  • STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation.

    abstract::Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the synthesis of prostaglandins, promotes the development of colorectal cancer, and is a key molecular target of non-steroidal anti-inflammatory drugs, compounds that reduce the relative risk of developing colon cancer. In this study, we showed that interferon gamm...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210015

    authors: Klampfer L,Huang J,Kaler P,Sasazuki T,Shirasawa S,Augenlicht L

    更新日期:2007-03-29 00:00:00

  • TGFβ signaling in head and neck squamous cell carcinoma.

    abstract::Transforming growth factor beta (TGFβ) is a key regulator of epithelial cell proliferation, immune function and angiogenesis. Because TGFβ signaling maintains epithelial homeostasis, dysregulated TGFβ signaling is common in many malignancies, including head and neck squamous cell carcinoma (HNSCC). Defective TGFβ sign...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.306

    authors: White RA,Malkoski SP,Wang XJ

    更新日期:2010-10-07 00:00:00

  • Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I.

    abstract::We recently reported an interaction between the p14(ARF) protein and human topoisomerase I (Topo I) resulting in the stimulation of the relaxation activity of Topo I. Our data showed that the complex between the two proteins was located within the nucleolus. In the present work, we have investigated the regions of p14...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206214

    authors: Ayrault O,Karayan L,Riou JF,Larsen CJ,Séité P

    更新日期:2003-04-03 00:00:00

  • Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.

    abstract::Endothelial cells expressing fibroblast growth factor receptor-1 (FGFR-1) migrate and proliferate in response to treatment with FGF. We analysed ligand-induced migration and proliferation of porcine aortic endothelial cells expressing wild-type FGFR-1, point-mutated Y766F FGFR-1, unable to activate phospholipase C-gam...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201936

    authors: Landgren E,Klint P,Yokote K,Claesson-Welsh L

    更新日期:1998-07-23 00:00:00

  • Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

    abstract::After publication of this Article, the Authors noticed errors in some of the Figures. In Figures 2e, 2f-g, 4a, 4j, 5a and 6b, unmatched β-actin was inadvertently used as loading control for the immunoblots. These have been corrected using repeat data from a similar set of samples and the revised Figures containing mat...

    journal_title:Oncogene

    pub_type: 已发布勘误

    doi:10.1038/s41388-020-1283-7

    authors: Vantaku V,Putluri V,Bader DA,Maity S,Ma J,Arnold JM,Rajapakshe K,Donepudi SR,von Rundstedt FC,Devarakonda V,Dubrulle J,Karanam B,McGuire SE,Stossi F,Jain AK,Coarfa C,Cao Q,Sikora AG,Villanueva H,Kavuri SM,Lotan Y

    更新日期:2020-10-01 00:00:00

  • Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium.

    abstract::We previously described the oral-esophageal tissue-specific expression of cyclin D1 with the Epstein-Barr virus ED-L2 promoter in transgenic mice, and resulting dysplasia. Given the evidence for an interplay between environmental and genetic factors in esophageal squamous carcinogenesis, the aim of this study was to d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202296

    authors: Jenkins TD,Mueller A,Odze R,Shahsafaei A,Zukerberg LR,Kent R,Stoner GD,Rustgi AK

    更新日期:1999-01-07 00:00:00

  • Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.

    abstract::Signal transducers and activators of transcription (Stats) are known to transduce signals from the cell surface to the nucleus in cytokine receptor signaling. We examined the capacity of platelet-derived growth factor (PDGF) receptor to interact with and activate Stat molecules. Activation of the PDGF beta-receptor le...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201555

    authors: Valgeirsdóttir S,Paukku K,Silvennoinen O,Heldin CH,Claesson-Welsh L

    更新日期:1998-01-29 00:00:00

  • Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition.

    abstract::DNA double-stranded breaks (DSBs) elicit a checkpoint response that causes a delay in cell cycle progression. Early in the checkpoint response, histone H2AX is phosphorylated in the chromatin region flanking the DSB by ATM/ATR and DNA-PK kinases. The resulting foci of phosphorylated H2AX (gamma-H2AX) serve as a platfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.501

    authors: Macůrek L,Lindqvist A,Voets O,Kool J,Vos HR,Medema RH

    更新日期:2010-04-15 00:00:00

  • EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.579

    authors: Wu J,Patmore DM,Jousma E,Eaves DW,Breving K,Patel AV,Schwartz EB,Fuchs JR,Cripe TP,Stemmer-Rachamimov AO,Ratner N

    更新日期:2014-01-09 00:00:00

  • Cdc25B activity is regulated by 14-3-3.

    abstract::In the G2 phase cell cycle checkpoint arrest, the cdc25-dependent activation of cyclin B/cdc2, a critical step in regulating entry into mitosis, is blocked. Studies in yeast have demonstrated that the inhibition of cdc25 function involves 14-3-3 binding to cdc25. In humans, two cdc25 isoforms have roles in G2/M progre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204574

    authors: Forrest A,Gabrielli B

    更新日期:2001-07-19 00:00:00

  • The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.

    abstract::Small cell lung cancer (SCLC) is a disease characterized by aggressive clinical behavior and lack of effective therapy. Owing to its tendency for early dissemination, only a third of patients have limited-stage disease at the time of diagnosis. SCLC is thought to derive from pulmonary neuroendocrine cells. Although se...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.362

    authors: Kalari S,Jung M,Kernstine KH,Takahashi T,Pfeifer GP

    更新日期:2013-07-25 00:00:00

  • Snail silencing effectively suppresses tumour growth and invasiveness.

    abstract::The transcription factor Snail has been recently proposed as an important mediator of tumour invasion because of its role in downregulation of E-cadherin and induction of epithelial-mesenchymal transitions (EMT). This behaviour has led to the consideration of Snail as a potential therapeutic target to block tumour pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209997

    authors: Olmeda D,Jordá M,Peinado H,Fabra A,Cano A

    更新日期:2007-03-22 00:00:00

  • The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.

    abstract::Only humans and higher primates have high uric acid blood levels. Although high uric acid causes gout, it has been linked with human longevity because of its hypothetical antioxidant function. Recent studies reveal that p53 has significant roles in cellular metabolism. One example of this is an antioxidant function th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.119

    authors: Itahana Y,Han R,Barbier S,Lei Z,Rozen S,Itahana K

    更新日期:2015-04-02 00:00:00

  • Accumulated helix-destabilizing mutations in the leucine zipper of c-Fos leads to attenuation and temperature sensitivity of function.

    abstract::Fos protein heterodimerizes through one surface of an alpha-helical domain called the leucine zipper. We have investigated the effect of destabilizing this domain by multiply substituting small residues of its non-interacting surface with glycine. Ternary complex formation between mutated Fos, Jun and DNA was determin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Nicklin MJ,Zechner D,Kislyakova T

    更新日期:1993-07-01 00:00:00